Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 505697777 series 3562568
Content provided by WebMD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by WebMD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Psychedelics like ketamine, psilocybin, and MDMA are emerging as promising treatments for mood disorders that don’t respond to standard care. What has research shown using these compounds as therapeutic tools? How can psychedelics work in the brain to alleviate mental health symptoms? We spoke with Janette Leal, MD, a board-certified psychiatrist, about the psychedelics currently being studied, their potential to safely and effectively ease symptoms in supervised settings, how they may help rewire thought patterns, common misconceptions about psychedelic-assisted therapy, and why working with a trained clinician is essential.
See omnystudio.com/listener for privacy information.
107 episodes
))
